What are the treatment guidelines for Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Guidelines for Postural Orthostatic Tachycardia Syndrome (POTS)

The first-line treatment for POTS should focus on non-pharmacological interventions including increased fluid intake (2-3 liters daily), increased salt consumption (5-10g daily), compression garments, and a structured exercise program, followed by pharmacological therapy tailored to the specific POTS phenotype if symptoms persist. 1

Non-Pharmacological Management

Fluid and Salt Intake

  • Increase daily fluid intake to 2-3 liters per day 1
  • Increase salt consumption to 5-10g (1-2 teaspoons) of table salt daily 1
  • Encourage liberalized dietary sodium intake rather than salt tablets to minimize gastrointestinal side effects 1

Physical Countermeasures

  • Use waist-high compression garments to improve venous return 1
  • Implement physical counter-pressure maneuvers (leg-crossing, stooping, squatting, muscle tensing) during symptomatic episodes 1, 2
  • Elevate the head of the bed during sleep 1

Exercise Training

  • Begin with horizontal exercise (rowing, swimming, recumbent bike) to avoid upright posture that triggers symptoms 2
  • Progressively increase duration and intensity of exercise as fitness improves 2
  • Gradually add upright exercise as tolerated 2
  • Supervised training is preferable to maximize functional capacity 2

Pharmacological Management

Phenotype-Specific Approach

  • Hypovolemic POTS:

    • Fludrocortisone for volume expansion 1, 3
    • Oral fluid loading has a pressor effect and may require less volume than intravenous fluid infusion 1
  • Neuropathic POTS:

    • Midodrine (2.5-10 mg three times daily) to enhance vascular tone 1, 3
    • First dose in morning before rising and last dose no later than 4 PM to avoid supine hypertension 1
    • Pyridostigmine to enhance vascular tone 3
  • Hyperadrenergic POTS:

    • Beta-blockers (e.g., propranolol) to treat resting tachycardia 1, 4
    • Avoid medications that inhibit norepinephrine reuptake 1, 4

Medication Precautions

  • Monitor for supine hypertension with vasoconstrictors like midodrine 1
  • Use midodrine with caution in older males due to potential urinary outflow issues 1
  • Carefully adjust or withdraw medications that may cause hypotension 1
  • Avoid medications that lower CSF pressure or reduce blood pressure as they may exacerbate postural symptoms 1

Monitoring and Follow-up

  • Schedule follow-up at regular intervals: early review at 24-48 hours, intermediate follow-up at 10-14 days, and late follow-up at 3-6 months 1
  • Assess treatment response by monitoring:
    • Standing heart rate and symptom improvement 1
    • Peak symptom severity 1
    • Time able to spend upright before needing to lie down 1
    • Cumulative hours able to spend upright per day 1

Managing Associated Conditions

  • For patients with chronic fatigue syndrome and POTS, consider coenzyme Q10 and d-ribose 1
  • Low-dose naltrexone may help with pain, fatigue, and neurological symptoms 1
  • Transcutaneous vagal stimulation may help with autonomic dysfunction 1
  • For patients with anxiety, consider:
    • Education about the physiological process of anxiety and its interaction with POTS symptoms 5
    • Sensory grounding techniques to prevent dissociation during anxiety episodes 5
    • Breathing techniques and progressive muscle relaxation 5
    • Selective serotonin reuptake inhibitors (SSRIs) or neuromodulators at low doses with slow titration for severe anxiety 5

Important Considerations

  • There are currently no FDA-approved medications specifically for POTS 3, 6
  • For heart rates as high as 180 bpm, consider cardiac evaluation to rule out other arrhythmias before attributing solely to POTS 1
  • POTS is frequently associated with deconditioning, recent infections, chronic fatigue syndrome, and joint hypermobility syndrome 7

References

Guideline

Treatment of Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Exercise and non-pharmacological treatment of POTS.

Autonomic neuroscience : basic & clinical, 2018

Guideline

Treatment of Anxiety in Patients with Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacotherapy for postural tachycardia syndrome.

Autonomic neuroscience : basic & clinical, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.